Stada Arzneimittel is further expanding its footprint in the Middle East and North Africa (MENA) and Asia Pacific (APAC) regions with two recently penned deals.
Stada Expands In MENA And APAC As Emerging Markets Strategy Pays Dividends
Germany's Stada Arzneimittel has secured the rights to market the FITO self-care medical device in the Gulf Cooperation Council region, North Africa, the Middle East and selected Asian Countries, and the Nizoral antifungal cream in Vietnam, the Philippines and Thailand. Stada’s half-year results show that the company’s emerging markets strategy is delivering results, with MENA and APAC contributing to the growth recorded by the Consumer Healthcare division.
